Indication
Relapsed follicular B-cell non-Hodgkin lymphoma
Relapsed follicular B-cell non-Hodgkin lymphoma describes a recurrent malignancy of the lymphatic system originating from germinal center B cells that reappears following a prior period of treatment-induced complete or partial remission. Read more about Relapsed follicular B-cell non-Hodgkin lymphoma
0 drugs 0 manufacturers
Drugs that treat it
Common Relapsed follicular B-cell non-Hodgkin lymphoma therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRelapsed follicular B-cell non-Hodgkin lymphoma describes a recurrent malignancy of the lymphatic system originating from germinal center B cells that reappears following a prior period of treatment-induced complete or partial remission.
Predominantly affecting older adults, this indolent lymphoproliferative disorder characteristically involves the lymph nodes, spleen, and bone marrow.
It is pathophysiologically defined by abnormal follicular architecture and sustained cell survival, most often driven by the t(14;18) chromosomal translocation that causes BCL2 overexpression.
Clinically, recurrence presents as newly enlarged or progressive painless lymphadenopathy, organomegaly, cytopenias, or constitutional B symptoms after prior therapy.
- nih.gov
Relapsed follicular B-cell non-Hodgkin lymphoma describes a recurrent malignancy of the lymphatic system originating from germinal center B cells that reappears following a prior period of treatment-induced complete or partial remission
- lymphoma.org
Relapsed follicular B-cell non-Hodgkin lymphoma describes a recurrent malignancy of the lymphatic system originating from germinal center B cells that reappears following a prior period of treatment-induced complete or partial remission
- nih.gov
Predominantly affecting older adults, this indolent lymphoproliferative disorder characteristically involves the lymph nodes, spleen, and bone marrow
- news-medical.net
Predominantly affecting older adults, this indolent lymphoproliferative disorder characteristically involves the lymph nodes, spleen, and bone marrow
- nih.gov
It is pathophysiologically defined by abnormal follicular architecture and sustained cell survival, most often driven by the t(14;18) chromosomal translocation that causes BCL2 overexpression
- theflf.org
Clinically, recurrence presents as newly enlarged or progressive painless lymphadenopathy, organomegaly, cytopenias, or constitutional B symptoms after prior therapy
- gazyva.com
Clinically, recurrence presents as newly enlarged or progressive painless lymphadenopathy, organomegaly, cytopenias, or constitutional B symptoms after prior therapy
Personalize your experience
Follow Relapsed follicular B-cell non-Hodgkin lymphoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.